Briggs v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided July 24, 2018·No. 15-737·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS Filed: June 27, 2018

********************* LAUREN BRIGGS, parent and * UNPUBLISHED next friend of E.B., a minor, * * No. 15-737V Petitioner, * v. * Special Master Gowen * SECRETARY OF HEALTH * Interim Attorneys’ Fees and Costs; AND HUMAN SERVICES, * Attorney Rates; Excessive Billing. * Respondent. * *********************

Richard Gage, Richard Gage & Associates, Cheyenne, Wyoming, for petitioner. Voris E. Johnson, United States Department of Justice, Washington, DC, for respondent.

DECISION ON INTERIM ATTORNEYS’ FEES AND COSTS1

On June 1, 2018, Lauren Briggs (“petitioner”), as parent and next friend of E.B., a minor, filed an application for interim attorneys’ fees and costs. Petitioner’s Interim Application (“Pet. Int. App.”) (ECF No. 50). For the reasons discussed below, the undersigned GRANTS petitioner’s application and awards a total of $38,801.80 in interim attorneys’ fees and costs.

I. Procedural History

On October 30, 2013, petitioner contacted the current counsel of record, Richard Gage, regarding filing a claim in the National Vaccine Injury Compensation Program (“Vaccine Act” or “Vaccine Program”).2 After petitioner and her counsel obtained medical records from

1 Pursuant to the E-Government Act of 2002, see 44 U.S.C. § 3501 note (2012), because this decision contains a reasoned explanation for the action in this case, I intend to post it on the website of the United States Court of Federal Claims. The court’s website is at http://www.uscfc.uscourts.gov/aggregator/sources/7. Before the decision is posted on the court’s website, each party has 14 days to file a motion requesting redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). “An objecting party must provide the court with a proposed redacted version of the decision.” Id. If neither party files a motion for redaction within 14 days, the decision will be posted on the court’s website without any changes. Id. 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-10 to 34 (2012) (hereinafter “Vaccine Act” or “the Act”). Hereinafter, individual section references will be to 42 U.S.C. § 300aa of the Act. multiple providers, she filed the petition on July 16, 2015. Petition (ECF No. 1). The petition asserts that E.B. received a Menactra (meningococcal) vaccination on August 2, 2012. Petition at 1. Petitioner alleges that the meningococcal vaccination caused E.B. to develop aplastic anemia. Id. On October 14, 2015, respondent filed a Rule 4(c) report recommending against compensation. Respondent’s Report (“Resp. Rept.”) (ECF No. 9).

Petitioner retained a medical toxicologist and clinical immunologist, Dr. Vera S. Byers, who presented multiple theories connecting the meningococcal vaccination to aplastic anemia. Pet. Exhibit (“Ex”) 8 at 9. Dr. Byers concluded, to a reasonable degree of medical certainty, that the meningococcal vaccination caused E.B.’s aplastic anemia. Id.

On October 26, 2016, respondent filed responsive reports from Dr. Penelope A. Morel, an immunologist with training in rheumatology, and Dr. John Strouse, a board certified pediatric hematologist/oncologist. Dr. Strouse opined that there is no scientific evidence of an association between vaccinations and aplastic anemia. Resp. Ex. C. Dr. Morel added that none of E.B.’s physicians considered the meningococcal vaccination to contribute to her condition. Resp. Ex. A.

On December 20, 2016, I held a status conference pursuant to Vaccine Rule 5. I reviewed the initial expert reports and raised multiple questions that should be addressed in supplemental expert reports. Scheduling Order (ECF No. 29). Petitioner filed Dr. Byers’s second report on May 22, 2017. Pet. Ex. 10. Respondent filed Dr. Morel and Dr. Strouse’s respective second reports on July 12, 2017. Resp. Exs. Y, FF.

During a status conference on August 8, 2017, I encouraged the parties to discuss the possibility of settlement. Petitioner noted in a status report on September 22, 2017, that she made a settlement demand. Status Report (ECF No. 41). Respondent declined the settlement demand and “wishe[d] to continue to defend the case….” Status Report (ECF No. 49). Subsequently, I set an entitlement hearing for Thursday, October 17, 2019 and Friday, October 18, 2019. Scheduling Order (ECF No. 48).

On June 1, 2018, petitioner filed the present application for interim attorneys’ fees and costs. Petitioner requests $18,765.53 in attorneys’ fees and $21,587.29 in costs. Thus, the total interim request is for $40,352.82. See Pet. Int. App. at 4.3

On June 6, 2018, respondent filed a response to petitioner’s motion. Resp. Response (ECF No. 51). Here, “respondent defers to the special master to determine whether or not petitioner has met the legal standard for interim attorneys’ fees and costs award, as set forth in Avera v. Secretary of Health and Human Services, 515 F.3d 1345 (Fed. Cir. 2008).” Id. at 2. “Respondent respectfully recommends that the special master exercise his discretion and

3 The interim fee application does not include a signed statement by petitioner confirming that she has not paid a retainer to counsel or incurred any other costs in the prosecution of this claim, in accordance with General Order Number 9. I will not require petitioner to submit such a statement in support of the interim application. However, petitioner should be sure to submit the General Order Number 9 statement in support of any final attorneys’ fees and costs application.

2 determine a reasonable award for attorneys’ fees and costs.” Id. at 3. Petitioner did not file a reply. Thus, this matter is now ripe for review.

II. Analysis

A. Interim Attorneys’ Fees and Costs

Section 15(e) of the Vaccine Act permits an award of reasonable attorneys’ fees and costs. In addition, the Vaccine Act permits interim attorneys’ fees and costs. See Avera, 515 F.3d at 1352; Shaw v. Sec’y of Health & Human Servs., 609 F.3d 1372 (Fed. Cir. 2010). When a petitioner has yet to prove entitlement, the special master may grant an interim award of reasonable attorneys’ fees and costs if the special master “determines that the petition was brought in good faith and there was a reasonable basis for the claim.” § 15(e)(1)(B); Sebelius v. Cloer, 133 S. Ct. 1886, 1893 (2013). I find that this claim was brought in good faith and on a reasonable basis.

In Shaw, the Federal Circuit held that it was proper to grant an interim award when “the claimant establishes that the cost of litigation has imposed an undue hardship.” 609 F.3d at 1375 (emphasis added). In Avera, the Federal Circuit stated that “[i]nterim fees are particularly appropriate in cases where proceedings are protracted and costly experts must be retained.” 515 F.3d at 1352. I do not routinely grant interim fee applications.

Free access — add to your briefcase to read the full text and ask questions with AI

Briggs v. Secretary of Health and Human Services, (uscfc 2018).

Briggs v. Secretary of Health and Human Services (Briggs v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related